Edgewise Therapeutics, Inc. (EWTX) Balance Sheet
As of 2026-06-30 (10-Q), Edgewise Therapeutics, Inc. (EWTX) reported total assets of $479.7M, total liabilities of $31.6M and shareholders' equity of $448.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $72.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EWTXEdgewise Therapeutics, Inc.Follow EWTX — free
—
Price chart with a free account
- Market cap
- 4.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15.6 | 22.0 | 86.1 | 41.7 | 61.1 | 72.3 | |
| Current assets | 283.8 | 357.0 | 327.0 | 475.5 | 543.4 | 471.5 | |
| Total assets | 285.2 | 367.1 | 340.0 | 486.8 | 552.6 | 479.7 | |
| Current liabilities | 10.5 | 16.6 | 16.8 | 23.9 | 27.4 | 29.0 | |
| Total liabilities | 10.9 | 20.4 | 21.2 | 27.6 | 30.3 | 31.6 | |
| Shareholders' equity | 274.4 | 346.7 | 318.8 | 459.2 | 522.3 | 448.1 |
USD millions · SEC XBRL
Edgewise Therapeutics, Inc. — questions
- How much cash does Edgewise Therapeutics, Inc. have?
- $72.3M in cash and cash equivalents as of 2026-06-30.
- What are Edgewise Therapeutics, Inc.'s total assets?
- $479.7M as of 2026-06-30.
- What is Edgewise Therapeutics, Inc.'s shareholders' equity?
- $448.1M as of 2026-06-30.
Every figure on this page comes from Edgewise Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.